{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T23:57:54Z","timestamp":1779148674168,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81173535"],"award-info":[{"award-number":["81173535"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673872"],"award-info":[{"award-number":["81673872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974520"],"award-info":[{"award-number":["81974520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.phymed.2021.153683","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T14:15:08Z","timestamp":1626876908000},"page":"153683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["A UPLC-MS\/MS-based metabolomics analysis of the pharmacological mechanisms of rabdosia serra against cholestasis"],"prefix":"10.1016","volume":"91","author":[{"given":"Kaihui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufeng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangle","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huanhuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengyu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenchen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaozhan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2021.153683_bib0001","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.5072","article-title":"Metabolomic investigation of cholestasis in a rat model using ultra-performance liquid chromatography\/tandem mass spectrometry","author":"Aoki","year":"2011","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.phymed.2021.153683_bib0002","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.5604\/01.3001.0010.5497","article-title":"Bile acids in cholestasis and its treatment","volume":"16","author":"Arab","year":"2017","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.phymed.2021.153683_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2017.09.019","article-title":"Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations","author":"Cariello","year":"2018","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.phymed.2021.153683_bib0004","doi-asserted-by":"crossref","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","author":"Chiang","year":"2018","journal-title":"Gene Expr"},{"key":"10.1016\/j.phymed.2021.153683_bib0005","article-title":"Identification of a Sister Gene to P-Glycoprotein","author":"Childs","year":"1995","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.phymed.2021.153683_bib0006","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mas.21562","article-title":"Challenges and emergent solutions for LC-MS\/MS based untargeted metabolomics in diseases","volume":"37","author":"Cui","year":"2018","journal-title":"Mass Spectrometry Rev."},{"key":"10.1016\/j.phymed.2021.153683_bib0007","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1021\/acs.jproteome.7b00838","article-title":"Targeted metabolomics reveals a protective role for basal PPAR\u03b1 in cholestasis induced by \u03b1-naphthylisothiocyanate","volume":"17","author":"Dai","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.phymed.2021.153683_bib0008","article-title":"Review: the bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease","author":"Daruich","year":"2019","journal-title":"Mol. Vis"},{"key":"10.1016\/j.phymed.2021.153683_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","author":"Ding","year":"2015","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.phymed.2021.153683_bib0010","doi-asserted-by":"crossref","DOI":"10.1152\/physiol.00020.2008","article-title":"The role of FXR in disorders of bile acid homeostasis","author":"Eloranta","year":"2008","journal-title":"Physiology"},{"key":"10.1016\/j.phymed.2021.153683_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112103","article-title":"Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice","volume":"245","author":"Fan","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2021.153683_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2019.00276","article-title":"Metabolomics and lipidomics reveal the effect of hepatic Vps33b deficiency on bile acids and lipids metabolism","volume":"10","author":"Fu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153683_bib0013","doi-asserted-by":"crossref","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.phymed.2021.153683_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27744","article-title":"Fibrates and cholestasis","author":"Ghonem","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2021.153683_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13880","article-title":"Novel and emerging therapies for cholestatic liver diseases","author":"Goldstein","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.phymed.2021.153683_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2017.10.166","article-title":"Mitochondria protection as a mechanism underlying the hepatoprotective effects of glycine in cholestatic mice","author":"Heidari","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phymed.2021.153683_bib0017","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.09.004","article-title":"Pathogenesis of cholestatic liver disease and therapeutic approaches","author":"Hirschfield","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2021.153683_bib0018","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M109326200","article-title":"Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor","author":"Kast","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2021.153683_bib0019","doi-asserted-by":"crossref","DOI":"10.7150\/ijms.24146","article-title":"Manual acupuncture relieves bile acid-induced itch in mice: the role of microglia and TNF-\u03b1","author":"Lee","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.phymed.2021.153683_bib0020","doi-asserted-by":"crossref","DOI":"10.1161\/ATVBAHA.115.305317","article-title":"SREBF2-Embedded mir33 links the nuclear bile acid receptor FXR to cholesterol and lipoprotein metabolism","author":"Lefebvre","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phymed.2021.153683_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2017.06.001","article-title":"Mechanisms of bile acid mediated inflammation in the liver","author":"Li","year":"2017","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.phymed.2021.153683_bib0022","doi-asserted-by":"crossref","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.phymed.2021.153683_bib0023","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-016-1697-8","article-title":"Role of AMP-activated protein kinase \u03b11 in 17\u03b1-ethinylestradiol-induced cholestasis in rats","author":"Li","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.phymed.2021.153683_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153438","article-title":"5-Hydroxy-4-methoxycanthin-6-one alleviates dextran sodium sulfate-induced colitis in rats via regulation of metabolic profiling and suppression of NF-\u03baB\/p65 signaling pathway","volume":"82","author":"Liu","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2021.153683_bib0025","article-title":"Identification of a nuclear receptor for bite acids","volume":"80-","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.phymed.2021.153683_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2015.01.020","article-title":"Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis","author":"Meng","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153683_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092287","article-title":"Pharmacokinetic and pharmacodynamic properties of rosmarinic acid in rat cholestatic liver injury","author":"Min","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2021.153683_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.4613","article-title":"Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine","author":"Sun","year":"2012","journal-title":"Phyther. Res."},{"key":"10.1016\/j.phymed.2021.153683_bib0029","doi-asserted-by":"crossref","DOI":"10.1124\/mol.116.106617","article-title":"Orally administered berberine modulates hepatic lipid metabolism by altering microbial bile acid metabolism and the intestinal FXR signaling pathway","author":"Sun","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153683_bib0030","first-page":"1","article-title":"Creating a reliable mass spectral \u2013 retention time library for all ion","volume":"9","author":"Tada","year":"2019","journal-title":"Metabol"},{"key":"10.1016\/j.phymed.2021.153683_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2016.08.049","article-title":"Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice","author":"Tang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2021.153683_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","author":"Thomas","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2021.153683_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2011.01.042","article-title":"Potential role of metabolomics apporoaches in the area of traditional Chinese medicine: As pillars of the bridge between Chinese and Western medicine","author":"Wang","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.phymed.2021.153683_bib0034","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-018-0110-y","article-title":"18\u03b2-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1\/FXR signaling pathway","author":"Wu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2021.153683_bib0035","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14126","article-title":"Effects of corilagin on alleviating cholestasis via farnesoid X receptor-associated pathways in vitro and in vivo","author":"Yang","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153683_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00116","article-title":"Dioscin protects ANIT-induced intrahepatic cholestasis through regulating transporters, apoptosis and oxidative stress","author":"Yao","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153683_bib0037","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2018.3859","article-title":"Identification of potential biomarkers in cholestasis and the therapeutic effect of melatonin by metabolomics, multivariate data and pathway analyses","author":"Yu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phymed.2021.153683_bib0038","article-title":"Xiaoyan lidan formula ameliorates \u03b1-naphthylisothiocyanate-induced intrahepatic cholestatic liver injury in rats as revealed by non-targeted and targeted metabolomics","author":"Zhang","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.phymed.2021.153683_bib0039","doi-asserted-by":"crossref","DOI":"10.5582\/bst.2018.01247","article-title":"Anti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury","author":"Zhang","year":"2019","journal-title":"Biosci. Trends."},{"key":"10.1016\/j.phymed.2021.153683_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2016.00085","article-title":"Untargeted metabolomics reveals dose-response characteristics for effect of rhubarb in a rat model of cholestasis","author":"Zhang","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153683_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.00001","article-title":"High-throughput metabolomics method for discovering metabolic biomarkers and pathways to reveal effects and molecular mechanism of ethanol extract from epimedium against osteoporosis","volume":"11","author":"Zhao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2021.153683_bib0042","article-title":"PPAR\u03b1 activation protects against cholestatic liver injury","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2021.153683_bib0043","doi-asserted-by":"crossref","DOI":"10.1038\/aps.2017.98","article-title":"D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress","author":"Zhao","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2021.153683_bib0044","article-title":"Paeoniflorin protects against ANIT-induced cholestasis by ameliorating oxidative stress in rats","author":"Zhao","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2021.153683_bib0045","doi-asserted-by":"crossref","DOI":"10.1002\/jhbp.537","article-title":"Modulation of transport and metabolism of bile acids and bilirubin by chlorogenic acid against hepatotoxicity and cholestasis in bile duct ligation rats: involvement of SIRT1-mediated deacetylation of FXR and PGC-1\u03b1","author":"Zhu","year":"2018","journal-title":"J. Hepatobiliary. Pancreat. Sci."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321002269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711321002269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:30:38Z","timestamp":1760553038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711321002269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":45,"alternative-id":["S0944711321002269"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153683","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A UPLC-MS\/MS-based metabolomics analysis of the pharmacological mechanisms of rabdosia serra against cholestasis","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2021.153683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153683"}}